Publication Name	World Journal of Gastroenterology
Manuscript ID	3384
Country	Italy

Received	2013-04-26 08:52
Peer-Review Started	2013-04-26 20:10
To Make the First Decision	2013-06-09 10:04
Return for Revision	2013-06-20 19:08
Revised	2013-07-10 00:28
Second Decision	2013-07-18 17:31
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-07-19 01:20
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-08-29 18:40
Publish the Manuscript Online	2013-09-14 11:17

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Autobiography
Article Title	Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation
Manuscript Source	Invited Manuscript
All Author List	Daniele Nicolini, Gianluca Svegliati-Baroni, Roberto Candelari, Cinzia Mincarelli, Alessandra Mandolesi, Italo Bearzi, Federico Mocchegiani, Andrea Vecchi, Roberto Montalti, Antonio Benedetti, Andrea Risaliti and Marco Vivarelli
Funding Agency and Grant Number
Corresponding Author	Daniele Nicolini, MD, Division of Hepatobiliary and Transplant Surgery, Department of Gastroenterology and Transplantation, Polytechnic University of Marche, Ospedali Riuniti, via Conca n° 71, 60129 Ancona, Italy. nicolini_daniele@yahoo.it
Key Words	Liver transplantation; Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Doxorubicin-eluting bead; Tumor histology; Recurrence-free survival; Locoregional therapies
Core Tip	The manuscript reports the experience with a newer technique of transcatheter arterial chemoembolization (TACE) that uses doxorubicin-eluting beads (DEB) for the treatment of hepatocellular carcinoma in liver transplant candidates. The results of DEB-TACE were compared to those of conventional TACE, and remarkably, a significantly higher recurrence-free survival after liver transplantation was observed in patients who were treated with DEB-TACE. The histological pattern observed in the area surrounding the tumor nodules of DEB-TACE patients was characterized by an intense inflammatory and fibrotic reaction, which could play a role in limiting tumor spread during waiting list time.
Publish Date	2013-09-14 11:17
Citation	Nicolini D, Svegliati-Baroni G, Candelari R, Mincarelli C, Mandolesi A, Bearzi I, Mocchegiani F, Vecchi A, Montalti R, Benedetti A, Risaliti A, Vivarelli M. Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation. World J Gastroenterol 2013; 19(34): 5622-5632
URL	http://www.wjgnet.com/1007-9327/full/v19/i34/5622.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i34.5622

Full Article (PDF)	WJG-19-5622.pdf
Manuscript File	3384-Review.docx
Answering Reviewers	3384-Answering reviewers.pdf
Copyright License Agreement	3384-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	EDITORIAL CERTIFICATE by American Journal Experts.pdf
Peer-review Report	3384-Peer review(s).docx
Scientific Editor Work List	3384-Scientific editor work list.doc